Naseem Amin - 07 Jun 2023 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role: Director
Signature: /s/ Naseem Amin
Issuer symbol: BLPH
Transactions as of: 07 Jun 2023
Transactions value $: $0
Form type: 4
Filing time: 09 Jun 2023, 16:12:24 UTC
Previous filing: 14 Feb 2023
Next filing: 21 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLPH	Common Stock	Award	$0	+47,578	+19.5%	$0.000000	291,865	07 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 47,578 restricted stock units granted under the Issuer's 2015 Equity Incentive Compensation Plan. The restricted stock units vest in full on December 31, 2023. This grant of restricted stock units was approved by the Compensation Committee of the Board of Directors of the Issuer on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the restricted stock units were granted, which was approved by stockholders on June 7, 2023.

Content

Represents 47,578 restricted stock units granted under the Issuer's 2015 Equity Incentive Compensation Plan. The restricted stock units vest in full on December 31, 2023. This grant of restricted stock units was approved by the Compensation Committee of the Board of Directors of the Issuer on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the restricted stock units were granted, which was approved by stockholders on June 7, 2023.